7-Chloroquinazoline-2,4(1H,3H)-dione

This compound is typically obtained as a crystalline solid ranging from white to off-white. Its molecular formula is C8H5ClN2O2, corresponding to a molecular weight of 196.59. The melting point generally exceeds 300 °C, with decomposition observed upon prolonged heating above this range. The calculated density is approximately 1.61 g/cm³ under ambient conditions. It exhibits limited solubility in common organic solvents such as methanol, ethanol, and acetone, but dissolves more readily in polar aprotic solvents like dimethyl sulfoxide and dimethylformamide. The compound is practically insoluble in water and nonpolar solvents such as dichloromethane and hexane. The molecule consists of a quinazoline-2,4-dione core with a chlorine atom at the 7position. The NH groups are weakly acidic and can participate in hydrogen bonding, while the carbonyl oxygens serve as hydrogen bond acceptors. Storage in tightly sealed containers protected from light and moisture at ambient temperature is generally adequate, though desiccated conditions are recommended for prolonged periods. Contact with strong oxidizing agents and strong bases should be avoided.

7Chloroquinazoline-2,4(1H,3H)-dione is a halogenated derivative of the quinazoline-2,4-dione scaffold, a fused bicyclic system consisting of a benzene ring fused to a pyrimidine-2,4-dione ring. This core structure, also known as a quinazolinedione, represents a privileged scaffold in medicinal chemistry due to its structural similarity to naturally occurring nucleotides and its ability to engage in multiple hydrogen bonding interactions through the NH and carbonyl groups. The chlorine atom at the 7position introduces electronwithdrawing character and provides a versatile handle for further functionalization through nucleophilic aromatic substitution or transitionmetalcatalyzed crosscoupling reactions. The rigid, planar architecture imposes conformational constraint, which can enhance binding selectivity and metabolic stability in drug candidates. This combination of a hydrogenbonding heterocyclic core with a modifiable halogen makes the compound a valuable building block for constructing molecules with potential activity against various therapeutic targets, including enzymes involved in cancer and inflammation.

Pharmaceutical Intermediate
In drug discovery, this chloroquinazolinedione is employed as a building block for synthesizing compounds with potential activity against cancer and inflammatory diseases. The quinazoline-2,4-dione core can serve as a bioisostere for quinazoline or purine scaffolds, engaging in key hydrogen bonding interactions with enzyme active sites such as kinases and phosphodiesterases. The chlorine atom enables latestage diversification through crosscoupling reactions, allowing systematic exploration of structureactivity relationships. Derivatives prepared from this scaffold have shown promise as inhibitors of epidermal growth factor receptor and other oncology targets.

Building Block for Heterocyclic Systems
The compound serves as a precursor for constructing more complex fused heterocyclic systems through further annulation reactions. The NH groups can be alkylated or acylated, while the chlorine provides a handle for introducing aryl or heteroaryl substituents that can participate in ringforming reactions. These transformations enable access to polycyclic quinazoline derivatives with enhanced pharmacological properties, including improved target selectivity and metabolic stability.

Ligand for Metal Complexes
The quinazoline-2,4-dione core can coordinate to transition metals through the carbonyl oxygens and ring nitrogens, forming complexes with welldefined geometries. Metal complexes derived from this scaffold are studied for their catalytic activity and as models for metalloenzyme active sites. The chlorine substituent can influence the electronic properties of the metal center, enabling finetuning of reactivity in catalytic applications such as oxidation and crosscoupling reactions.

Materials Science Applications
The rigid, planar structure and hydrogenbonding capacity of this quinazolinedione derivative make it valuable for designing organic semiconductors and supramolecular materials. Incorporation into conjugated polymers or coordination polymers yields materials with tunable optoelectronic properties for applications in organic lightemitting diodes and fieldeffect transistors. The ability to form strong hydrogen bonds also enables the construction of selfassembled monolayers and crystalline frameworks with defined pore architectures for gas storage and separation.